Detalhe da pesquisa
1.
Discovery and SAR of 2-arylbenzotriazoles and 2-arylindazoles as potential treatments for Duchenne muscular dystrophy.
Bioorg Med Chem Lett
; 21(16): 4828-31, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21741236
2.
Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy.
J Clin Invest
; 114(12): 1726-31, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15599397
3.
Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.
PLoS One
; 6(5): e19189, 2011 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21573153
4.
Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy.
J Med Chem
; 54(9): 3241-50, 2011 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21456623
5.
Transduction patterns of pseudotyped lentiviral vectors in the nervous system.
Mol Ther
; 9(1): 101-11, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14741783